Frontlight ResearchEarly access
Rheumatoid arthritis trials in China
7 of 53 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationMass Spectrometry-based Immune Profiling in Autoimmune Diseases
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07188285 - No phaseTaking peopleClinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
- Where
- Shanghai
- Age
- 18 years and over
- People
- 10,000
- Run by
- Dongyi He
See details and how to joinNCT07484243 - No phaseTaking peopleProspective Cohort Study on Refractory Rheumatoid Arthritis
- Where
- Beijing
- Age
- 18 years and over
- People
- 200
- Run by
- Peking University Third Hospital
See details and how to joinNCT07126431 - No phaseTaking peopleEfficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 30
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT07491016 - No phaseTaking peopleA RWS of SC MTX in Chinese RA Patients
- Where
- Beijing
- Age
- 18 years and over
- People
- 10,000
- Run by
- Peking University People's Hospital
See details and how to joinNCT07463937 - No phaseTaking peopleEfficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
- Where
- Hangzhou
- Age
- 18 years to 85 years
- People
- 20
- Run by
- Zhejiang Provincial People's Hospital
See details and how to joinNCT06979271 - No phaseTaking peopleObservational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
- Where
- Beijing, Changsha, Chongqing, Hangzhou, Nanjing, Shenzhen
- Age
- Up to 18 years
- People
- 20,000
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06417502